Status | Study |
Recruiting |
Study Name: Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS Condition: Glut1 Deficiency Syndrome Date: 2013-12-03 Interventions: Drug: GLUT1 DS |
Active, not recruiting |
Study Name: Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome Condition: Glucose Transporter Type 1 Deficiency Syndrome Date: 2013-11-27 Interventions: Drug: Triheptanoin Triheptanoin (C7 oil) is a triglyceride of the anaplerotic odd-chain fatty acid hepto |
Active, not recruiting |
Study Name: Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) Condition: Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS) Date: 2013-10-31 Interventions: Drug: UX007 (triheptanoin) Tri |